iPLATO Text Messaging: Six times more effective for reaching Smokers

GP surgeries in Islington have found that using text messaging for smoking cessation campaigns (getting smokers to quit) is six times more effective than traditional ways of contacting patients. Leading Islington practices using the iPLATO text messaging system have reported patient response rates of 30% (versus a response rate of 5% using letters). By isolating patients on their GP system, surgeries can send out a text message asking patients to text back their current smoking status. Patients who indicate that they are still smokers and trying to quit are then invited to smoking cessation clinics.

“We sent a text message to 200 patients telling them that we were updating their medical record and asked - ‘pls. text back current non smoker; smoker & are you ready to quit?’; any patients indicating that they were still smoking were invited for smoking cessation support”, explains Charlotte Blyth, Practice Manager at the Elizabeth Avenue Surgery. She continues, “Using letters and even calling up patients to invite them to the surgery is a huge drain on surgery resources and staff time. With the iPLATO system we can contact hundreds of patients instantly without having to stuff a single envelope. Many of our own surgery staff were amazed at the rapid response, as the majority of patients responded within minutes. If we had run the same campaign using letters we would generally have to wait a few days to get any response.”

To put this initiative into perspective, 33.5% of the adult population in Islington smoke, compared to 26.5% in North Central London and 27.5% in England as a whole. Approximately 39 people per 10,000 die of smoking related causes in Islington, a rate higher than other boroughs in North Central London and London as a whole. Any means of reducing these numbers must be embraced and iPLATO Patient Care Messaging clearly fits this purpose.

David Thomas Head of Information at Islington Primary Care Trust who has led the expansion of the iPLATO text messaging service said, “Text messaging has a huge role to play in the way surgeries communicate with their patients, the immediacy and convenience of this medium has been illustrated by the positive results experienced by many of our surgeries. Islington PCT is dedicated to using innovative technologies to enhance patient services while giving patient greater choice in the way in which they receive health information; we see text messaging as one of the technologies.”

iPLATO’s Managing Director, Tobias Alpsten agrees with David Thomas saying “Over the years we have seen surgeries use our text messaging system to develop a relationship with their patients. Being able to offer support to patients trying to quit smoking in a way that makes them feel comfortable has a great impact on the success of such campaigns. iPLATO is the leading supplier of mobile healthcare solutions to GP surgeries in the U.K, we are committed to sharing best practice and encourage surgeries throughout our user base to use the mobile channel as a way to engage with their patients more effectively.”

- Ends -

Notes for Editors:

About Islington PCT

Islington PCT is responsible for all primary and community healthcare services for the Islington population. Primary care includes pharmacists, dentists, opticians and family doctors. Community care includes the provision of services such as health visits and district nursing. Islington is one of the most diverse boroughs in London. It has a highly mobile population with poor standards of health.

About iPLATO

iPLATO is a privately owned limited company founded in London in the autumn of 1999. In 2003, iPLATO was awarded a SMART Feasibility Grant by the Department of Trade & Industry to study the feasibility for national implementation of a system to remind outpatients about scheduled appointments using text messaging technology.

Since completing the study, the company has invested substantial resources towards overcoming the barriers to entry of the healthcare market and now provides successful healthcare solutions to NHS organisations throughout the United Kingdom - building a promising business around its flagship service ‘Patient Care Messaging’.

The European Venture Contest, organised by the European Commission, recognised iPLATO as one of the top ten early stage technology ventures ready to “reshape their industry and to conquer the global market” and featured on the Red Herring Europe Top 200 of companies to watch in 2006. iPLATO began 2008 with extensive (PCT funded) roll out of Patient Care Messaging to GP surgeries across 10 Primary Care Trusts.

Press contact:

Julia Hanley
020 3178 4676
julia.hanley@iplato.net 
One Lyric Square,  W6 0NB, London, United Kingdom
www.iplato.net
Pictures available on request